|
Mechanism30S subunit inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CA |
First Approval Date31 Dec 1981 |
100 Clinical Results associated with Fujian Nanshaolin Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Fujian Nanshaolin Pharmaceutical Co., Ltd.
100 Deals associated with Fujian Nanshaolin Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Fujian Nanshaolin Pharmaceutical Co., Ltd.